Vanta Bioscience Limited - Company Profile

Q: Where is Vanta Bioscience Limited headquartered?

Vanta Bioscience Limited is headquartered at No.02G308G No.3FfSf1-20-248 Umajay Complex Rasoolpura, Secunderabad, Telangana, 500003.

Q: Who are the current directors of Vanta Bioscience Limited?

The current directors of Vanta Bioscience Limited are Padmanabhuni Venkata Appaji, Dopesh Raja Mulakala, Yogeswara Rao Danda, Gonuguntla Kathyayani, Venkata Sathya Murali Dokka, Vidisha Vimal Hingu, Vyasmurti Madhavrao Shingatgeri.

It is a pharma public limited company based in Secunderabad, Telangana, India, established in 2016.

2016 Secunderabad, Telangana, India Active

Last Updated: December 21, 2025

Access Report

About Vanta Bioscience Limited

Vanta Bioscience Limited, a active public limited company, was established on 29 April 2016 in Secunderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: L74999TG2016PLC109280. Registered under ROC Roc Hyderabad. it is listed on BSE: 540729. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹7.11 Cr.

Formerly known as Vanta Bioscience Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹5.80 Cr and a net worth of ₹19.74 Cr. Employing 43 professional, Its leadership includes Padmanabhuni Venkata Appaji (Director), Dopesh Raja Mulakala (Managing Director), Yogeswara Rao Danda (Director). Past directors included Padmanabhuni Venkata Appaji, Dopesh Raja Mulakala, Jang Bahadur Gupta. It holds ₹12.32 Cr open charges and ₹17.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.02/G/308/G No.3/Ff/Sf/1-20-248 Umajay Complex Rasoolpura, Secunderabad, Telangana, 500003.

Company Details

CIN/LLPIN
L74999TG2016PLC109280
Registration Number
109280
Incorporation Date
29 April 2016
Authorized Capital
₹7.50 Cr
Paid-Up Capital
₹7.11 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 540729)
Company Status
Active

Key Metrics

Authorised Capital ₹ 7.50 Cr as on 21-12-2025
Paid Up Capital ₹ 7.11 Cr as on 21-12-2025
Company Age 9 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 12.32 Cr as on 21-12-2025
Satisfied Charges ₹ 17.00 Cr as on 21-12-2025
Revenue Growth **** -39.10% (FY 2023)
Profit Growth **** -5495.65% (FY 2023)
Ebitda **** -113.98% (FY 2023)
Net Worth -17.70% (FY 2023)
Total Assets **** 2.46% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Vanta Bioscience Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Vanta Bioscience Limited?

Current Directors

Name	Designation	Appointment Date	Status
Padmanabhuni Venkata Appaji	Director	20 Mar 2017	Current
Dopesh Raja Mulakala	Managing Director	29 Apr 2016	Current
Yogeswara Rao Danda	Director	22 May 2019	Current
Gonuguntla Kathyayani	Director	19 May 2017	Current
Vyasmurti Madhavrao Shingatgeri	Whole-Time Director	08 Feb 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	31 May 2017	Past
Pramod Abcsdd	Director	18 Apr 2017	Past
Pramod Abcsdd	Additional Director	31 May 2017	Past
Pramod Abcsdd	Chief Executive Officer	-	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Additional Director	27 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vanta Bioscience.

Vanta Bioscience Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.1% decrease. The company also saw a substantial fall in profitability, with a 5495.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.7%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-39.10%

*******

Revenue from Operations

*******

-44.69%

*******

Total Assets

*******

2.46%

*******

Profit or Loss

*******

-5495.65%

*******

Net Worth

*******

-17.70%

*******

EBITDA

*******

-113.98%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vanta Bioscience?

In 2023, Vanta Bioscience had a promoter holding of 69.36% and a public holding of 30.65%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹123,200,000.00

Satisfied Charges

₹170,000,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 12.32 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Mar 2017	State Bank Of India	₹12.32 Cr	Open
03 Dec 2019	Axis Bank Limited	₹17.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vanta Bioscience?

Vanta Bioscience has a workforce of 43 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vanta Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanta Bioscience's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vanta Bioscience

Recent Activity within the Organization

Charges

A charge with State Bank Of India of Rs. 12.32 Cr registered on 27 Mar 2017 with Charge ID 100092316 was modified on 25 Mar 2025. was recorded as a recent event.
25 Mar 2025
Annual General Meeting

The activity Vanta Bioscience Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
30 Sep 2024
Balance Sheet

Progress on Vanta Bioscience Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
31 Mar 2024
Charges

A charge registered on 03 Dec 2019 via Charge ID 100311514 with Axis Bank Limited was fully satisfied on 26 Sep 2023. was recorded as a recent event.
26 Sep 2023
Director Appointment

The activity Vidisha Vimal Hingu was appointed as a Company Secretary was appointed as a Company Secretary on 15 Sep 2022 & has been associated with this company since 3 years 4 months . was completed.
15 Sep 2022
Director Appointment

The activity Venkata Sathya Murali Dokka was appointed as a CFO was appointed as a CFO on 11 Nov 2021 & has been associated with this company since 4 years 3 months . was completed.
11 Nov 2021

Explore recent activity and updates - View Recent Activity